Thomas Wilkie

Dr. Thomas Wilkie

UT Southwestern Medical Center
orcid

Biography

Thomas Wilkie is currently an Associate Professor of Pharmacology at UT Southwestern Medical Center in Dallas, a member of the SCCC at UTSW, an Adjunct Faculty Member of Biological Sciences at UT Dallas, the Director of the Cancer Discovery Group, and a member of the Biosample subcommittee of the PRECEDE Consortium to develop early PDA diagnostics and prognostics. Tom has a BA in Biochemistry (UC Berkeley, 1980) and PhD in Biochemistry (UW Seattle, 1986) and conducted his postdoctoral research with Melvin Simon (California Institute of Technology, 1992). As a postdoc, Tom cloned many new G alpha subunit genes in mice and defined the four functional classes of metazoan G alpha subunits: Gq, Gi, G12 and Gs. Soon after starting his own laboratory, he showed that Regulators of G-protein Signaling (RGS proteins) are GTPase activating proteins (GAPs) for Gi (and Gq) class alpha subunits, in collaboration with A. Gilman. He then showed that RGS proteins are regulated by calcium-calmodulin and PIP3 to initiate calciumoscillations evoked by Gq-coupled GPCR agonists in pancreatic acinar cells, in collaboration with S. Muallem. A current goal of the Wilkie Laboratory is to determine the role of G-protein/RGS regulation during the initiation and progression of PDA in people with pancreatitis, metabolic syndrome, obesity and type 2 diabetes.

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.